Combined Inhibition of Cyclin-Dependent Kinases (Dinaciclib) and AKT (MK-2206) Blocks Pancreatic Tumor Growth and Metastases in Patient-Derived Xenograft Models
2015 ◽
Vol 14
(7)
◽
pp. 1532-1539
◽
Keyword(s):
Keyword(s):
2011 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2013 ◽
Keyword(s):